Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30609972 | 0.94 | ALDH1A1 (0.40) | CD81ALDH1A1PPARGGRIK2TP53 | |
| SCHEMBL20082 | 0.94 | ALDH1A1 (0.40) | CD81ALDH1A1PPARGGRIK2TP53 | |
| SCHEMBL28302 | 0.94 | ALDH1A1 (0.40) | CD81ALDH1A1PPARGGRIK2TP53 | |
| SCHEMBL5179069 | 0.94 | ALDH1A1 (0.40) | CD81ALDH1A1PPARGGRIK2TP53 | |
| SCHEMBL29640472 | 0.94 | ALDH1A1 (0.40) | CD81ALDH1A1PPARGGRIK2TP53 | |
| Bicarbonate SCHEMBL20401648 | 0.92 | ALDH1A1 (0.39) | CD81ALDH1A1PPARGGRIK2TP53 | |
| Ethylene SCHEMBL4370792 | 0.91 | ALDH1A1 (0.42) | CD81ALDH1A1PPARGGRIK2TP53 | |
| SCHEMBL8512429 | 0.89 | ALDH1A1 (0.37) | CD81ALDH1A1PPARGGRIK2TP53 | |
| Alcohol SCHEMBL28952323 | 0.89 | ALDH1A1 (0.37) | CD81ALDH1A1PPARGGRIK2TP53 | |
| SCHEMBL29832859 | 0.89 | ALDH1A1 (0.37) | CD81ALDH1A1PPARGGRIK2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3004033-B1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | TRASIS S A (BE) | 2019-05-08 | — | — | EP | claimed |
| US-9839702-B2 | Method for purification of 18F-labeled choline analogues | TRASIS S.A. (BE) | 2017-12-12 | — | — | US | claimed |
| EP-2148836-B1 | METHOD FOR THE PREPARATION OF REACTIVE [18]F FLUORIDE | TRASIS S A (BE) | 2017-10-25 | — | — | EP | claimed |
| US-20160129139-A1 | Method for Purification of 18F-Labeled Choline Analogues | TRASIS S.A. (BE) | 2016-05-12 | — | — | US | claimed |
| EP-3004033-A1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | Trasis S.A. (BE) | 2016-04-13 | — | — | EP | claimed |
| EP-2845608-A1 | Method for purification of 18F-labeled choline analogues | Trasis S.A. (BE) | 2015-03-11 | — | — | EP | claimed |
| WO-2014195249-A1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | TRASIS S.A. (BE) | 2014-12-11 | — | — | WO | claimed |
| US-8641903-B2 | Method for the preparation of reactive [18] F fluoride | TRASIS S.A. (BE) | 2014-02-04 | — | — | US | claimed |
| US-20100243972-A1 | METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE | TRASIS S.A. (BE) | 2010-09-30 | — | — | US | claimed |
| EP-2148836-A1 | METHOD FOR THE PREPARATION OF REACTIVE Ý18¨F FLUORIDE | Universite de Liege (BE) | 2010-02-03 | — | — | EP | claimed |
| WO-2008128306-A1 | METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE | TRASIS S.A. (BE) | 2008-10-30 | — | — | WO | claimed |
| WO-2024035925-A2 | N-CYCLOPROPYL-1-(4-(4-(FLUORO-18F)PHENYL)PYRIMIDIN-5-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE AND USES IN PET IMAGING | EMORY UNIVERSITY (US) | 2024-02-15 | — | — | WO | disclosed |
| US-20230158178-A1 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | UNIV EMORY (US) | 2023-05-25 | — | — | US | disclosed |
| EP-4121121-A1 | RADIONUCLIDE TRACERS OF 1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES THEREOF | Emory University (US) | 2023-01-25 | — | — | EP | disclosed |
| US-11384106-B2 | Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers | EMORY UNIVERSITY (US) | 2022-07-12 | — | — | US | disclosed |
| WO-2014195249-A1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | TRASIS S.A. (BE) | 2014-12-11 | — | — | WO | disclosed |
| US-8641903-B2 | Method for the preparation of reactive [18] F fluoride | TRASIS S.A. (BE) | 2014-02-04 | — | — | US | disclosed |
| US-20100243972-A1 | METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE | TRASIS S.A. (BE) | 2010-09-30 | — | — | US | disclosed |
| EP-2148836-A1 | METHOD FOR THE PREPARATION OF REACTIVE Ý18¨F FLUORIDE | Universite de Liege (BE) | 2010-02-03 | — | — | EP | disclosed |
| WO-2008128306-A1 | METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE | TRASIS S.A. (BE) | 2008-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160129139-A1 | Method for Purification of 18F-Labeled Choline Analogues | SLC5A7, CHAT, CHKA | CD81 3031/4885ALDH1A1 2903/4885PPARG 3076/4885 |
| US-20230158178-A1 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | AFF1, METTL3, VHL | CD81 356/4885ALDH1A1 243/4885PPARG 989/4885 |
| US-11384106-B2 | Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers | SLC16A8, S100A8, FGF23 | CD81 1226/4885ALDH1A1 1595/4885PPARG 1992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.